Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

SpyGlass Pharma, Inc. (SGP) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

SpyGlass Pharma, Inc. (SGP), most recent 12 months reported: net loss $39.87M, free cash flow -$33.49M. Latest balance sheet on file: liquid cash $234.19M. From SEC filings. Others in Surgical & Medical Instruments & Apparatus: enVVeno Medical Corp · Odyssey Health, Inc. · PROFUSA, INC. · Polyrizon Ltd. · PolyPid Ltd · RETINALGENIX TECHNOLOGIES INC. · StimCell Energetics Inc. · WORK Medical Technology Group LTD

Stock screener

Watchlist